Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database.
about
Advances in rheumatology: new targeted therapeuticsPain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbidityCertolizumab pegol for treating axial spondyloarthritis.Indirect comparison between subcutaneous biologic agents in ankylosing spondylitis.The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.
P2860
Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Ankylosing spondylitis patient ...... matology association database.
@ast
Ankylosing spondylitis patient ...... matology association database.
@en
type
label
Ankylosing spondylitis patient ...... matology association database.
@ast
Ankylosing spondylitis patient ...... matology association database.
@en
prefLabel
Ankylosing spondylitis patient ...... matology association database.
@ast
Ankylosing spondylitis patient ...... matology association database.
@en
P2093
P2860
P356
P1476
Ankylosing spondylitis patient ...... matology association database.
@en
P2093
Andrew Briggs
Bridie Murphy
John Oldroyd
Lionel Schachna
Margaret Staples
Marissa Lassere
Molly Bond
P2860
P304
P356
10.1155/2009/268569
P577
2009-08-02T00:00:00Z